"The committee has been plagued with persistent conflicts of interest and has become little more than a rubber stamp for any ...

The drug is not the first nasal spray to treat migraine, but it's anticipated to work more rapidly — the medication is intended to offer relief within 15 minutes, according to Pfizer.

News of the FDA’s approval came after two randomized, double-blind, placebo-controlled studies. Future Publishing via Getty Images. Pfizer touts quick pain relief as the biggest benefit of Zavzpret.

The FDA has approved Pfizer's nasal spray to treat migraines in adults. The medication, called Zavzpret, is expected to be available via a doctor's prescription in July 2023.

How can severe weather in North Carolina affect medication availability in Las Vegas? Skip to content. Drive for Good. Surprise Squad. Take 5 to Care. Honor Flight Southern Nevada. A+ Educators.

The FDA has updated labels on the top two COVID-19 vaccines to warn of a rare heart side effect, mostly seen in young men.

The U.S. Food and Drug Administration has approved Pfizer's newest drug on the migraine market, Zavzpret (zavegepant) -- the first and only migraine treatment of its kind to be offered in nasal spray.

It’s the only medication that can treat a migraine when it strikes and prevent migraine attacks,” she said in the ad. 5 Gaga said she started to experience migranes as a teenager.

Now, after 25 years of research, scientists at Vertex Pharmaceuticals figured out how to block this same pain pathway with suzetrigine, leading to a new pain medication for the FDA to approve.

A tornado severely damaged a Pfizer pharmaceutical plant site in North Carolina, exacerbating drug shortages nationwide. Skip to content NOWCAST WBAL-TV 11 News at 4pm ...

Levicept arose from the metaphorical ashes of Pfizer’s former R&D campus in the U.K. Now, the biotech has scored a phase 2 win for an osteoarthritis drug that can also be traced back to the Big ...

The Food and Drug Administration on Thursday approved Zavzpret, a new nasal spray designed to treat migraines, with the potential to work in just 15 minutes. The drug, which Pfizer acquired when ...